Nutrition and benign prostatic hyperplasia
- PMID: 23202286
- DOI: 10.1097/MOU.0b013e32835abd05
Nutrition and benign prostatic hyperplasia
Abstract
Purpose of review: Nutrition seems to modify the pathogenesis of benign prostatic hyperplasia (BPH) effect symptomology in men suffering from lower urinary tract symptoms (LUTS). Although there are numerous pharmaceuticals and procedures for these conditions, nutrition may improve outcomes as a primary approach or in tandem with BPH medications or procedures. The purpose of this review is to highlight the benefits of nutrition and dietary supplements in men with BPH and LUTS.
Recent findings: Dietary factors have an impact on metabolic disorders that lead to diabetes and obesity - both of which inversely effect BPH and LUTS. Dietary patterns associated with increased risks include starches and red meats, whereas moderate alcohol intake and polyunsaturated fat and vegetable consumption decrease risks. Dietary supplements of zinc, saw palmetto, and beta-sitosterol in relieving BPH symptoms have had mixed results. Randomized clinical trials of nutritional practices and other lifestyle alterations such as exercise for the prevention or treatment of BPH and LUTS have yet to be performed.
Summary: Nutritional practices may provide for the prevention and treatment of BPH and LUTS while positively affecting other systemic parameters. Whereas there are a few clinical randomized trials for the prevention and treatment of BPH and LUTS, nutritional modifications may have a healthy lifestyle alternative with minimal to no adverse effects.
Similar articles
-
Associations of obesity, physical activity and diet with benign prostatic hyperplasia and lower urinary tract symptoms.Curr Opin Urol. 2014 Jan;24(1):10-4. doi: 10.1097/MOU.0000000000000004. Curr Opin Urol. 2014. PMID: 24247174 Review.
-
Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.Maturitas. 2012 Nov;73(3):180-5. doi: 10.1016/j.maturitas.2012.07.007. Epub 2012 Aug 9. Maturitas. 2012. PMID: 22883375 Review.
-
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21726934 Review.
-
Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.Int J Clin Pract. 2011 Sep;65(9):1005-13. doi: 10.1111/j.1742-1241.2011.02731.x. Epub 2011 Jul 1. Int J Clin Pract. 2011. PMID: 21718399 Review.
-
Benign prostate hyperplasia and nutrition.Clin Nutr ESPEN. 2019 Oct;33:5-11. doi: 10.1016/j.clnesp.2019.07.015. Epub 2019 Aug 12. Clin Nutr ESPEN. 2019. PMID: 31451276
Cited by
-
Treatment of Benign Prostatic Hyperplasia by Natural Drugs.Molecules. 2021 Nov 25;26(23):7141. doi: 10.3390/molecules26237141. Molecules. 2021. PMID: 34885733 Free PMC article. Review.
-
Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.Sci Rep. 2016 May 12;6:25778. doi: 10.1038/srep25778. Sci Rep. 2016. PMID: 27170414 Free PMC article.
-
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.Neoplasia. 2017 Jun;19(6):451-459. doi: 10.1016/j.neo.2017.04.005. Epub 2017 May 7. Neoplasia. 2017. PMID: 28494348 Free PMC article.
-
Sex-Specific Multimorbidity-Multibehaviour Patterns in Primary Care Populations.Int J Environ Res Public Health. 2025 Mar 24;22(4):485. doi: 10.3390/ijerph22040485. Int J Environ Res Public Health. 2025. PMID: 40283714 Free PMC article.
-
Impact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol.Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1431-43. doi: 10.1152/ajprenal.00674.2014. Epub 2015 Apr 8. Am J Physiol Renal Physiol. 2015. PMID: 25855514 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials